Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sekhsaria Chemicals was a prominent Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and fine chemicals. The company was globally recognized as a leading producer of Atenolol, a widely prescribed beta-blocker for cardiovascular conditions. Operating manufacturing facilities in Dombivli, India, Sekhsaria Chemicals served major international markets, including the United States and Europe, by maintaining high quality standards and regulatory compliance. In 2000, the company was acquired by Clariant Chemicals (India) Limited as part of its strategy to expand its life science business. The manufacturing assets were later integrated into Arch Pharmalabs following a subsequent divestment by Clariant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sekhsaria Chemicals.